MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    White matter lesions and motor symptoms in Parkinson’s disease

    S. Jost, A. Sauerbier, A. Rizos, M. Picillo, D. van Wamelen, V. Stopic, JN. Petry-Schmelzer, M. Schönfeld, N. Abdullayev, K. Ashkan, K. Rukavina, J. Jarosz, M. Sommerauer, M. Qamar, R. Cury, E. Fonoff, M. Dos Santos-Ghilardi, A. Othman, M. Muthuraman, GR. Fink, A. Antonini, L. Timmermann, P. Martinez-Martin, A. Fasano, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: Objective: To investigate the association between cerebral white matter lesions (WML) and motor symptoms in Parkinson’s disease (PD). Background: Background: Previous studies have shown…
  • 2023 International Congress

    Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease

    K. Brockmann, JC. Corvol, A. Difonzo, S. Durrleman, T. Gasser, M. Hu, R. Krüger, I. Liepelt-Scarfone, M. Matarazzo, A. Pilotto, T. Simuni, P. Svenningsson, D. Weintraub, G. Pagano (Tuebingen, Germany)

    Objective: To prevent cognitive decline in GBA-associated Parkinson’s Disease (PD). Background: Dementia represents a key milestone in the course of PD with limited effective treatments…
  • 2023 International Congress

    Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report

    S. Kazanci, M. Afshari, J. Fleisher (Chicago, USA)

    Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…
  • 2023 International Congress

    Needs assessment of patients with Parkinson’s disease: a qualitative study

    N. Geraminejad, A. Darvishpoor Kakhki (Tehran, Islamic Republic of Iran)

    Objective: This research was conducted with a qualitative approach to assess the needs of patients with Parkinson's disease Background: In the health system, the provision…
  • 2023 International Congress

    Risk of Parkinson’s disease in spinal cord injury: a nationwide cohort study in south Korea

    JH. Ahn, KD. Han, H. Choi, W. Jung, JW. Cho, J. Youn, DW. Shin (Seoul, Republic of Korea)

    Objective: In the present population-based study, we investigated the association of PD with SCI according to the severity of disability and injured spinal cord level,…
  • 2023 International Congress

    Prognostic significance of peripheral neutrophils and lymphocytes in early Parkinson’s disease

    JS. Jun, R. Kim (Seoul, Republic of Korea)

    Objective: To explore whether peripheral blood neutrophils and lymphocytes are associated with longitudinal motor and cognitive decline in patients with early Parkinson’s disease (PD) and,…
  • 2023 International Congress

    Benefits of Physician-Pharmacist Collaboration on Patient Outcomes in Parkinson’s Disease and Movement Disorders Clinic

    P. Techa-Angkoon, Y. Pitakpatapee, W. Saengphatrachai, P. Srivanitchapoom, T. Suansanae (Bangkok, Thailand)

    Objective: To evaluate the impact of pharmacist participation in Parkinson’s disease and movement disorders clinic on the number of drug-related problems (DRPs), clinical outcomes, and…
  • 2023 International Congress

    Hypothalamic involvement in Multiple System Atrophy: a clinical and neuroimaging study

    J. Pasquini, M. Firbank, L. Best, V. Foster, R. Ceravolo, G. Petrides, K. Anderson, D. Brooks, N. Pavese (Pisa, Italy)

    Objective: To investigate hypothalamic atrophy and its clinical correlates in Multiple System Atrophy (MSA) through MRI. Background: MSA is characterized by autonomic dysfunction, i.e. orthostatic…
  • 2023 International Congress

    Pallidal DBS improves myoclonus in 2 patients with post-hypoxic myoclonus

    L. Pan, A. Mogilner, S. Frucht (New York, USA)

    Objective: Describe DBS for 2 patients with severe post-hypoxic myoclonus. Background: Limited prior reports have shown improvement of PHM after DBS. We describe 2 recent…
  • 2023 International Congress

    Hypnosis as an adjunctive treatment for FND, a case series

    J. Chen, J. Waugh, K. Brewer-Mixon, S. Chitnis, D. Morris (Dallas, USA)

    Objective: To review three cases of Functional Neurologic Disorder (FND) that resolved successfully with Hypnosis and to identify the specific techniques and reasons behind their…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley